Page last updated: 2024-08-26

bosentan anhydrous and Cardiac Output, Low

bosentan anhydrous has been researched along with Cardiac Output, Low in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arner, A; Dou, Y; Garmaroudi, FS; Hegele, RG; Laher, I; Luo, H; Luo, Z; Marchant, D; McDonough, JE; McManus, BM; Si, X; Walker, E1
Bell, SP; Chen, Z; LeWinter, MM; Noguchi, T; Nyland, L1
Charles, CJ; Espiner, EA; Frampton, CM; Nicholls, MG; Rademaker, MT; Richards, AM1

Trials

1 trial(s) available for bosentan anhydrous and Cardiac Output, Low

ArticleYear
Combined inhibition of angiotensin II and endothelin suppresses the brain natriuretic peptide response to developing heart failure.
    Clinical science (London, England : 1979), 2004, Volume: 106, Issue:6

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Bosentan; Cardiac Output; Cardiac Output, Low; Cardiac Pacing, Artificial; Cyclic GMP; Endothelin Receptor Antagonists; Endothelin-1; Female; Infusions, Parenteral; Losartan; Natriuretic Peptide, Brain; Renin; Sheep; Sulfonamides

2004

Other Studies

2 other study(ies) available for bosentan anhydrous and Cardiac Output, Low

ArticleYear
Bosentan enhances viral load via endothelin-1 receptor type-A-mediated p38 mitogen-activated protein kinase activation while improving cardiac function during coxsackievirus-induced myocarditis.
    Circulation research, 2009, Mar-27, Volume: 104, Issue:6

    Topics: Animals; Antihypertensive Agents; Bosentan; Cardiac Output, Low; Coxsackievirus Infections; Disease Models, Animal; Endothelin A Receptor Antagonists; Enterovirus B, Human; Enzyme Activation; Humans; Mice; Myocarditis; p38 Mitogen-Activated Protein Kinases; Stroke Volume; Sulfonamides; Viral Load

2009
Endothelin receptor blockade has an oxygen-saving effect in Dahl salt-sensitive rats with heart failure.
    American journal of physiology. Heart and circulatory physiology, 2003, Volume: 285, Issue:4

    Topics: Amiloride; Animals; Bosentan; Cardiac Output, Low; Echocardiography; Endothelin Receptor Antagonists; Energy Metabolism; Heart Function Tests; In Vitro Techniques; Male; Myocardial Contraction; Myocardium; Oxygen Consumption; Peptides, Cyclic; Rats; Rats, Inbred Dahl; Receptor, Endothelin A; Receptor, Endothelin B; Sodium-Hydrogen Exchangers; Sulfonamides

2003